Tumors induce angiogenesis by secreting pro-angiogenic molecules such as vascular endothelial growth factor A (VEGF-A), and VEGF-A inhibition has become a common therapeutic strategy for many cancers [9]. The gene discussed is VEGFA; the disease is cancer.